Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.
Renalyse has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Renalyse's investors include GENESIS Ventures, Eurostars, Mind the Gap program.
Renalyse is headquartered in Tarragona, Spain.
Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.
Renalyse is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Renalyse — Funding & Investors." VCBacked, October 9, 2023, https://www.vcbacked.co/company/renalyse. Accessed August 4, 2026.
VCBacked. (2023). Renalyse — Funding & Investors. Retrieved August 4, 2026, from https://www.vcbacked.co/company/renalyse
{{cite web |title=Renalyse — Funding & Investors |url=https://www.vcbacked.co/company/renalyse |website=VCBacked |access-date=August 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated